Implementing an Enhanced Integrated Respiratory MDT with Oxfordshire CCG Joint Working Project Executive Summary

Identification and optimisation of care for patients at risk of respiratory admission through an enhanced integrated multi-disciplinary team

A joint-working project between Oxfordshire Clinical Commissioning Group (OCCG) and Boehringer Ingelheim Ltd (BIL).

Long-term conditions (LTCs) are a significant burden to the NHS, with over 15 million people affected in England, consuming over 70% of primary and secondary care budgets1. Chronic obstructive pulmonary disease (COPD) is a long-term condition and the second most common lung disease in the UK, affecting 1.2 million people2. The annual direct care costs of COPD in England are £1.5bn3, a significant burden to the NHS. COPD is the second most common cause of emergency admissions to hospital and one of the most costly inpatient conditions to be treated by the NHS4. Oxfordshire Clinical Commissioning Group and Boehringer Ingelheim have designed this joint-working project to run across the North and City localities of Oxfordshire with the aim of improving outcomes and experience of care for respiratory patients.

The project seeks to improve a number of patient outcome measures by coordinating service provision around the needs of patients by forming a multi-disciplinary integrated respiratory team (IRT). This aims to enhance existing community and hospital-based teams by increasing consultant, nursing and physiotherapist resource and integrating with specialist GPs, a psychologist, a pharmacist, dedicated smoking-free advisor and specialist palliative care support.

The IRT will take a person-centred approach5, as defined by National Voices’ Narrative for Person-Centred Care as follows: “I can plan my care with people who work together to understand me and my carer(s), allow me control and bring together services to achieve the outcomes important to me.’

This pilot aims to provide more timely and coordinated care closer to home for patients. This proactive and preventative approach aims to reduce system costs by reducing emergency department attendances, non-elective admissions and re-admissions. The pilot will start in November 2018 run for 20 months and inform future commissioning of services across Oxfordshire.

Boehringer Ingelheim is pleased to collaborate with the NHS across Oxfordshire and explore the challenges and support needed to implement an integrated, multi-disciplinary care pathway. We are keen to take and share the learning from this project with the wider healthcare community to further support improvements in patient care.

References

  1.  Department of Health and Social Care. Long Term Conditions Compendium of Information: Third Edition. 2012. Available at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/216528/dh_134486.pdf (last accessed: 9th October 2018)

  2. British lung Foundation Chronic obstructive pulmonary disease (COPD) statistics Available at: https://statistics.blf.org.uk/copd?_ga=2.172364004.659029904.1539085999-1533914209.1533029613&_gac=1.175433110.1539085999.EAIaIQobChMIioXOj6b53QIVVeh3Ch1Qcw0AEAAYASAAEgJHMPD_BwE (last accessed 9th October 2018)

  3. Literature review: the economic costs of lung disease and the cost effectiveness of policy and service interventions British Thoracic Society October 2017 Available at: http://allcatsrgrey.org.uk/wp/download/respiratory_diseases/download.pdf (last accessed October 2020)

  4. Department of Health and Social Care (2012), An Outcomes Strategy for COPD and Asthma: NHS Companion Document, [online] Available from: https://www.gov.uk/government/publications/an-outcomes-strategy-for-copd-and-asthma-nhs-companion-document (Accessed 9th October 2018)

  5. A Narrative for Person-Centred Coordinated Care National Voices People Shaping Health and Social Care 2013 NHS England Publication Gateway Reference Number: 00076 

 

NP-GB-101253 V2 Respiratory  November 2022